Profile data is unavailable for this security.
Mergers & acquisitions
Acquired company | BMY:NYQ since announced | Transaction value |
---|---|---|
RayzeBio Inc | -13.55% | 4.21bn |
Karuna Therapeutics Inc | -11.82% | 14.40bn |
LianBio-Mavacamten Greater China Rights | -19.28% | 350.00m |
Mirati Therapeutics Inc | -20.22% | 5.12bn |
Data delayed at least 15 minutes, as of Apr 26 2024 20:20 BST.
Holder | Shares | % Held |
---|---|---|
Bram Bradesco Asset Management S/A DTVMas of 31 Dec 2023 | 4.92k | 0.00% |
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.